Skip to main content

Table 2 Clinical characteristics of the patients

From: Excretion of complement proteins and its activation marker C5b-9 in IgA nephropathy in relation to renal function

Classification

(The number of biopsies and range of glomeruli)

TP

(g/dl)

s-Cr

(mg/dl)

u-Protein

(g/g•Cr)

u-NAG

(10-3U/mg•Cr)

u-Bm

(ng/mg•Cr)

u-MAC

(ng/mg•Cr)

Good prognosis

(n = 6, 7.5 ± 4.5)

7.3 ± 0.6

0.64 ± 0.18

0.41 ± 0.19

3.6 ± 2.3*

57.7 ± 17.3

0.3 ± 0.8

Relatively good prognosis

(n = 17, 15.3 ± 9.6)

7.4 ± 0.3**

0.80 ± 0.19

0.39 ± 0.36*

3.6 ± 2.0*

110.2 ± 113.1

6.5 ± 11.0

Relatively poor prognosis

(n = 30, 13.0 ± 6.9)

7.0 ± 0.5

0.72 ± 0.23*

0.75 ± 0.67

4.5 ± 2.2*

222.9 ± 570.5

12.1 ± 24.9

Poor prognosis

(n = 18, 14.9 ± 9.6)

6.8 ± 0.4

0.98 ± 0.48

1.10 ± 0.92

9.3 ± 6.7

254.4 ± 528.3

25.4 ± 42.7

Total

(n = 71)

7.1 ± 0.5

0.80 ± 0.32

0.72 ± 0.70

5.4 ± 4.4

189.9 ± 458.4

14.0 ± 28.4

  1. (mean ± SD)
  2. *: p < 0.05 vs. poor prognosis,
  3. **:p < 0.05 vs. relatively poor prognosis and poor prognosis
  4. Abbreviations: TP, total protein; s-Cr, serum creatinine; u-Protein, urinary protein; u-NAG, urinary N-acetyl-β-D-glucosaminidase; u-Bm, u-β2 microglobulin; u-MAC, urinary membrane attack complex